Search database
LIST OPTIONS
Filter
55
Filtered Results: 55
Text search: psychostimulant
Featured
Language
Document type
No document type
42
Studies & Reports
6
Guidelines
5
Manuals
2
Countries / Regions
Kenya
1
Togo
1
Global
1
Germany
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Authors & Publishers
IACAPAP
17
World Health Organization WHO
7
et al.
5
World Health Organization
5
United Nations Office on Drugs and Crime
4
WHO
3
Deutsche Hauptstelle für Suchtfragen e.V.
2
J. Morris
2
S. Scott
2
World Health Organization (WHO)
2
A. Ivanenko
1
A. J. Flisher
1
A. K. Lam
1
A. Lachman
1
and I. Feijo
1
Bozorgmehr, K.
1
Bundeszentrale für gesundheitliche Aufklärung
1
Bundeszentrale für gesundheitliche Aufklärungc
1
E. B. Pérez
1
et. al.
1
European Monitoring Centre for Drugs and Drug Addiction
1
F. D. Zepf
1
F. D.Zepf
1
Global smart
1
H. Metzger
1
H. Ritchie
1
H. Ritchie and M. Roser
1
Hannah Metzger, Sina Wanderer & Veit Roessner
1
I. Feijo
1
J.
1
J. Starling
1
J. Strang
1
Joseph M. Rey, Francisco B. Assumpção Jr, Carlos A. Bernad, Füsun Çetin Çuhadaroğlu, Bonnie Evans, Daniel Fung, Gordon Harper, Loïc Loidreau, Yoshiro Ono, Dainius Pūras, Helmut Remschmidt, Brian Robertson, Olga A. Rusakoskaya, Kari Schleimer
1
K. Sorsdahl
1
M. Holtmann
1
M. Roser
1
mhGAP
1
Ministry of Health, Republic of Kenya
1
N. Metrebian
1
Organisation Mondiale de la Santé OMS
1
P. Hay
1
Plos Medicine
1
Prof. Dr. rer. nat. Gerd Glaeske Dr. med. Rüdiger Holzbach
1
Publications Office
1
Qreini, M.
1
R. Humeniuk, S. Henry-Edwards, R. Ali
1
R. Jahn
1
R. R. Althoff
1
Rajbongshi, S.
1
République togolaise, Ministère de la santé
1
RKI
1
Rohleder, S.
1
S. Cortese
1
S. Hatherill
1
S. Hung
1
S. Rohleder, M. Qreini, et al.
1
S. Seedat
1
S. Wanderer
1
Starling
1
T. D. Benton
1
T. Groshkova
1
U. Ramtekkar
1
UNAIDS
1
UNAIDS (Joint United Nations Programme on HIV/AIDS)
1
UNAIDS, UNODC (United Nations Office on Drugs and Crime)
1
UNHCR, WHO
1
United Nations
1
United Nations Office on Drug and Crime UNODC
1
United Nations Office on Drugs and Crime UNODC
1
V. Roessner
1
W.Cheung
1
Wai-him Cheung, Anna Kit-sum Lam & Se-fong Hung
1
World Drug Report 2017
1
World Health Organization WHO, Regional Office of Europe
1
World Health Organization WHO, UNICEF
1
World Health Organization, United Nations Office on Drugs and Crime
1
Publication Years
Category
MPOX - Monkeypox
2
Palliative Care
1
Countries
1
Health System Strengthening
1
Policies
1
Palliative Care
1
General Guidelines
1
Non-communicable Diseases
1
Toolboxes
Children/Adolescents Mental Disorders
18
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
17
Substance Use Disorders & Addiction
13
Substance Use Disorders, Others
9
Diverse Chemical Substances
4
Drugs
2
Schizophrenia
2
Germany
2
mhGAP Guides
2
People who injecting Drugs
2
Attention deficit hyperactivity disorder (ADHD)
2
Stress
2
IEC Substance Use Disorders
2
Cannabis
2
MPOX - Monkeypox
2
Global Overview
2
HIV in Key Populations
2
Alcohol
1
Cocaine
1
Posttraumatic stress disorder Adults
1
Mental Health
1
Policies & Programmes
1
Training Manuals
1
Eating Disorders
1
Opoids
1
Human Rights
1
Mental Health Guidelines
1
Epilepsy
1
Medical professionals
1
Reports
1
General
1
Waste Managment
1
Reports & Studies
1
Health Worker
1
Policies and guidelines
1
General
1
Community Worker
1
Mental disorders, others
1
TB/HIV Coinfection
1
Tobacco
1
HIV service delivery
1
Depression
1
Mental Health GAP Action Programme
1

Implementing Comprehensive HIV and HCV Programmes with People Who Inject Drugs

UNAIDS, UNODC (United Nations Office on Drugs and Crime); World Health Organization; et al. (2017) C2
Practical Guidance for collaborative interventions
Q7: What is the effectiveness, safety and role of pharmacological and non-pharmacological interventions, within non- specialist health care for children with a diagnosis of Attention-deficit hyperactivity disorder (ADHD)?
In this entry we are looking at smoking, alcohol consumption and the use of illicit drugs. We are studying who is using these substances, how their use has changed over time, and we are presenting the estimates of their impact on health. Collectively, smoking, alcohol and illicit drug use kills 11.8... more
2nd revised edition. Accessed Apri. 17, 2019 Prevention strategies based on scientific evidence working with families, schools, and communities can ensure that children and youth, especially the most marginalized and poor, grow and stay healthy and safe into adulthood and old age. For every dollar ... more

Synthetische Drogen - Basisinformation

Deutsche Hauptstelle für Suchtfragen e.V.; Bundeszentrale für gesundheitliche Aufklärungc (2017) C2

Treatment of psychostimulant dependence

World Health Organization (2012) C_WHO
Q3: Are pharmacotherapies safe and effective for the treatment of psychostimulant dependence (maintenance or relapse prevention) in non-specialized settings?
Externalising disorders Chapter D.3
Other disorders Chapter H.1
Published: February 23, 2010 https://doi.org/10.1371/journal.pmed.1000235 Volume 7 | Issue 2 | e1000235

Market Analysis of synthetic drugs

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
Amphetamine-type stimulants, new psychoactive substances -4- World Drug Report 2017 Accessed: 14.03.2019

Brief psychosocial interventions

World Health Organization (2012) C_WHO
Q1: Are brief psychosocial interventions for people using cannabis or psychostimulants effective in reducing drug use, dependence and harm from drug use?
SCOPING QUESTION:Which psychosocial interventions are effective in the treatment of psychostimulant dependence for adults and young people?
EMCDDA Insights - 11 Accessed: 14.03.2019
Manual for use in primary care. There is substantial evidence for the benefits of screening and brief intervention in primary health care for alcohol problems. However, there is a need for screening and brief interventions with cross-cultural relevance for substances other than alcohol or tobacco,... more

WHO mhGAP Guideline update

WHO WHO (2015) C_WHO
Update of the Mental Health Gap Action Programme (mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
Autres troubles Chapitre H.1 Edition en français Traduction : Priscille Gérardin et Malaïka Lasfar Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA